Algeria
Egypt
Israel
Jordan
Lebanon
Libya
Morocco
Palestine *
Syria *
TunisiaWhat is COVAX facility ?
COVAX is a global facility working on the equitable distribution of COVID-19 vaccines around the world. The initiative came to life through a partnership between the World Health Organization (WHO), Global Alliance for Vaccines and Immunisation (GAVI) and the Coalition for Epidemic Preparedness Innovations (CEPI). It includes 192 countries covering more than 7 billion people and ensures fair and equal access to COVID-19 vaccines supplied through UNICEF.
«Europe is investing in COVAX, both financially and by sharing vaccines. Because we believe this is the best way to ensure universal, fair and affordable access to COVID-19 vaccines. Our common goal is to leave no one behind.» President von der Leyen
From the start, the European Union and its Member States (Team Europe) have been one of the lead contributors to COVAX with close to EUR 3 billion for the COVAX Facility, which remains the key global vehicle to ensure fair and equitable access to these vaccines and delivers on international vaccine solidarity. To complement COVAX’s efforts, Team Europe is aiming to donate at least 200 million doses to partner countries before the end of the year. A majority is expected to be delivered through COVAX.
Amount of vaccines per country*:
- Algeria: 1,728,000
- Egypt: 4,689,280
- Jordan: 477,750
- Lebanon: 439,050
- Libya: 230,190
- Morocco: 1,260,000
- Syria: 431,520
- Tunisia: 2,235,510
- West Bank and Gaza: 808,400
For more information
EU’s international solidarity during the COVID-19 pandemic
*Numbers as of 10/09/2021
Countries covered:
-
Algeria
-
Egypt
-
Israel
-
Jordan
-
Lebanon
-
Libya
-
Morocco
-
Palestine *
-
Syria *
-
Tunisia
